HomeCGTX • NASDAQ
add
Cognition Therapeutics Inc
Previous close
$0.32
Day range
$0.31 - $0.33
Year range
$0.28 - $2.95
Market cap
19.85M USD
Avg Volume
831.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.78M | -2.32% |
Net income | -8.48M | 7.33% |
Net profit margin | — | — |
Earnings per share | -0.14 | 48.15% |
EBITDA | -13.75M | 2.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.43M | -52.62% |
Total assets | 23.50M | -39.51% |
Total liabilities | 11.23M | 12.40% |
Total equity | 12.27M | — |
Shares outstanding | 61.99M | — |
Price to book | 1.58 | — |
Return on assets | -128.18% | — |
Return on capital | -212.13% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.48M | 7.33% |
Cash from operations | -9.88M | -36.35% |
Cash from investing | — | — |
Cash from financing | 1.30M | -89.19% |
Net change in cash | -8.58M | -280.69% |
Free cash flow | -9.95M | -40.48% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
25
